Eurofins Scient (OTCMKTS:ERFSF) and XWELL (NASDAQ:XWEL) Head to Head Contrast

Eurofins Scient (OTCMKTS:ERFSF) and XWELL (NASDAQ:XWEL) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.

Valuation & Earnings

This table compares Eurofins Scient and XWELL”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eurofins Scient	$7.52 billion	1.68	$439.77 million	N/A	N/A
XWELL	$30.60 million	0.16	-$16.85 million	($3.37)	-0.26

Eurofins Scient has higher revenue and earnings than XWELL.

Analyst Ratings

This is a summary of recent ratings for Eurofins Scient and XWELL, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eurofins Scient	0	6	0	1	2.29
XWELL	1	0	0	0	1.00

Profitability

This table compares Eurofins Scient and XWELL’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Eurofins Scient	N/A	N/A	N/A
XWELL	-63.18%	-265.41%	-72.67%

Volatility and Risk

Eurofins Scient has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, XWELL has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Institutional & Insider Ownership

8.7% of XWELL shares are owned by institutional investors. 13.9% of XWELL shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Eurofins Scient beats XWELL on 8 of the 11 factors compared between the two stocks.

About Eurofins Scient

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

About XWELL

XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs. The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.